PMID- 25224693 OWN - NLM STAT- MEDLINE DCOM- 20160115 LR - 20161125 IS - 1095-9130 (Electronic) IS - 1046-2023 (Linking) VI - 77-78 DP - 2015 May TI - Analysis of PTEN ubiquitylation and SUMOylation using molecular traps. PG - 112-8 LID - S1046-2023(14)00287-4 [pii] LID - 10.1016/j.ymeth.2014.09.001 [doi] AB - The function of the tumour suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is tightly controlled by post-translational modifications (PTMs) including ubiquitin or Small Ubiquitin-related MOdifiers (SUMO). It is known that SUMOylation by SUMO-1, SUMO-2/-3, mono- or polyubiquitylation have a distinct impact on PTEN activity, localisation and/or stability, however the molecular mechanisms governing these processes are still unclear. Studying PTM regulated events has always been a difficult task due to their labile nature. Here, we propose an update on the role of these PTMs on PTEN function, as well as a methodological overview on the use of molecular traps named SUMO Binding Entities (SUBEs) or Tandem Ubiquitin Binding Entities (TUBEs) to capture SUMOylated or Ubiquitylated forms of PTEN respectively. When combined with in vitro SUMOylation or Ubiquitylation assays, the use of molecular traps facilitate the detection of modified forms of PTEN. SUMO and ubiquitin-traps are also suitable to capture endogenously modified forms of PTEN after expression of E3 ligases or treatment with chemical inhibitors. This versatile approach represents an interesting alternative to explore PTEN regulation by SUMO and ubiquitin under physiological or pathological conditions. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Lang, Valerie AU - Lang V AD - Inbiomed, Ubiquitylation and Cancer Molecular Biology Laboratory, Cancer Unit Mikeletegi 81, 20009 San Sebastian-Donostia, Spain. Electronic address: vlang@inbiomed.org. FAU - Aillet, Fabienne AU - Aillet F AD - Inbiomed, Ubiquitylation and Cancer Molecular Biology Laboratory, Cancer Unit Mikeletegi 81, 20009 San Sebastian-Donostia, Spain. Electronic address: faillet@inbiomed.org. FAU - Da Silva-Ferrada, Elisa AU - Da Silva-Ferrada E AD - Inbiomed, Ubiquitylation and Cancer Molecular Biology Laboratory, Cancer Unit Mikeletegi 81, 20009 San Sebastian-Donostia, Spain. Electronic address: edasilva@inbiomed.org. FAU - Xolalpa, Wendy AU - Xolalpa W AD - Inbiomed, Ubiquitylation and Cancer Molecular Biology Laboratory, Cancer Unit Mikeletegi 81, 20009 San Sebastian-Donostia, Spain. Electronic address: wendyxolalpa@gmail.com. FAU - Zabaleta, Lorea AU - Zabaleta L AD - Inbiomed, Ubiquitylation and Cancer Molecular Biology Laboratory, Cancer Unit Mikeletegi 81, 20009 San Sebastian-Donostia, Spain. Electronic address: lzabaleta@inbiomed.org. FAU - Rivas, Carmen AU - Rivas C AD - Dpt Biologia Molecular y Celular, Centro Nacional de Biotecnologia-CSIC, Darwin 3, Madrid 28049, Spain; Centro de Investigacion en Medicina Molecular y Enfermedades Cronicas (CIMUS), Universidad de Santiago de Compostela, Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela E15706, Spain. Electronic address: mcarmen.rivas@usc.es. FAU - Rodriguez, Manuel S AU - Rodriguez MS AD - Inbiomed, Ubiquitylation and Cancer Molecular Biology Laboratory, Cancer Unit Mikeletegi 81, 20009 San Sebastian-Donostia, Spain. Electronic address: msrodriguez@inbiomed.org. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140916 PL - United States TA - Methods JT - Methods (San Diego, Calif.) JID - 9426302 RN - 0 (Tumor Suppressor Proteins) RN - EC 3.1.3.67 (PTEN Phosphohydrolase) RN - EC 3.1.3.67 (PTEN protein, human) SB - IM MH - HEK293 Cells MH - Humans MH - PTEN Phosphohydrolase/*genetics/*metabolism MH - Protein Processing, Post-Translational/physiology MH - Sumoylation/*physiology MH - Tumor Suppressor Proteins/*genetics/*metabolism MH - Ubiquitination/*physiology OTO - NOTNLM OT - Degradation OT - PTEN OT - Proteasome OT - Proteolysis OT - SUMOylation OT - Ubiquitylation EDAT- 2014/09/17 06:00 MHDA- 2016/01/16 06:00 CRDT- 2014/09/17 06:00 PHST- 2014/07/21 00:00 [received] PHST- 2014/08/29 00:00 [revised] PHST- 2014/09/03 00:00 [accepted] PHST- 2014/09/17 06:00 [entrez] PHST- 2014/09/17 06:00 [pubmed] PHST- 2016/01/16 06:00 [medline] AID - S1046-2023(14)00287-4 [pii] AID - 10.1016/j.ymeth.2014.09.001 [doi] PST - ppublish SO - Methods. 2015 May;77-78:112-8. doi: 10.1016/j.ymeth.2014.09.001. Epub 2014 Sep 16.